Susac Syndrome in a Patient with Migraine Shortly After COVID-19 Booster Vaccination: More Than a Temporal Relation?

Overview

Journal J Neurol

Specialty Neurology

Date 2023 Nov 9

PMID 37943298

Authors

Stergios Tsitos

Adrian Danek

Andreas Straube

Affiliations

Soon will be listed here.

References

Dorr J, Krautwald S, Wildemann B, Jarius S, Ringelstein M, Duning T . Characteristics of Susac syndrome: a review of all reported cases. Nat Rev Neurol. 2013; 9(6):307-16. DOI: 10.1038/nrneurol.2013.82. View

Pereira S, Vieira B, Maio T, Moreira J, Sampaio F . Susac's Syndrome: An Updated Review. Neuroophthalmology. 2021; 44(6):355-360. PMC: 7746245. DOI: 10.1080/01658107.2020.1748062. View

Gross C, Meyer C, Bhatia U, Yshii L, Kleffner I, Bauer J . CD8 T cell-mediated endotheliopathy is a targetable mechanism of neuro-inflammation in Susac syndrome. Nat Commun. 2019; 10(1):5779. PMC: 6920411. DOI: 10.1038/s41467-019-13593-5. View

Ashina M, Hansen J, Do T, Melo-Carrillo A, Burstein R, Moskowitz M . Migraine and the trigeminovascular system-40 years and counting. Lancet Neurol. 2019; 18(8):795-804. PMC: 7164539. DOI: 10.1016/S1474-4422(19)30185-1. View

Pietrobon D, Moskowitz M . Pathophysiology of migraine. Annu Rev Physiol. 2012; 75:365-91. DOI: 10.1146/annurev-physiol-030212-183717. View

Karatas H, Erdener S, Gursoy-Ozdemir Y, Lule S, Eren-Kocak E, Sen Z . Spreading depression triggers headache by activating neuronal Panx1 channels. Science. 2013; 339(6123):1092-5. DOI: 10.1126/science.1231897. View

Kleffner I, Dorr J, Ringelstein M, Gross C, Bockenfeld Y, Schwindt W . Diagnostic criteria for Susac syndrome. J Neurol Neurosurg Psychiatry. 2017; 87(12):1287-1295. DOI: 10.1136/jnnp-2016-314295. View

Novais F, Carvalho A, Clark M, Carvalho L, Beiting D, Brodsky I . CD8+ T cell cytotoxicity mediates pathology in the skin by inflammasome activation and IL-1β production. PLoS Pathog. 2017; 13(2):e1006196. PMC: 5325592. DOI: 10.1371/journal.ppat.1006196. View

Bolay H, Karadas O, Ozturk B, Sonkaya R, Tasdelen B, Bulut T . HMGB1, NLRP3, IL-6 and ACE2 levels are elevated in COVID-19 with headache: a window to the infection-related headache mechanism. J Headache Pain. 2021; 22(1):94. PMC: 8358545. DOI: 10.1186/s10194-021-01306-7. View

10.

Coutre S, Barnett C, Osiyemi O, Hoda D, Ramgopal M, Fort A . Ibrutinib for Hospitalized Adults With Severe Coronavirus Disease 2019 Infection: Results of the Randomized, Double-Blind, Placebo-Controlled iNSPIRE Study. Open Forum Infect Dis. 2022; 9(5):ofac104. PMC: 8992313. DOI: 10.1093/ofid/ofac104. View